This week's Lab Notes has updates on two new drug candidates, one targeting a rare inherited disease and another for prostate cancer, plus a medical device manufacturer's $36.8 million stock sale.
This week's Lab Notes has updates on two new drug candidates, one targeting a rare inherited disease and another for prostate cancer, plus a medical device manufacturer's $36.8 million stock sale.
